Home/Radiance Biopharma/Marc E. Lippman, MD, MACP, FRCP
ME

Marc E. Lippman, MD, MACP, FRCP

Chairman of the Board

Radiance Biopharma

Therapeutic Areas

Radiance Biopharma Pipeline

DrugIndicationPhase
RB-601Cancer (tumors expressing c-MET and EGFR)Pre-clinical
RB-203Cancer (tumors expressing membrane Hsp70)Pre-clinical